Our new grading system offers a clear, data-backed signal of a financial institution’s strength. Our rating may have flagged ...

British pharmaceutical giant AstraZeneca said Tuesday it would invest $50 billion in the United States by 2030 amid Donald ...

"The broader market, however, failed to hold its momentum, reflecting increased uncertainty as ETF demand slows." While ...

British pharmaceutical giant AstraZeneca said Tuesday it would invest $50 billion in the United States amid a looming ...